Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20,683 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Interim analysis of the efficiency and safety of neoadjuvant PD-1 inhibitor (sintilimab) combined with chemotherapy (nab-paclitaxel and carboplatin) in potentially resectable stage IIIA/IIIB non-small cell lung cancer: a single-arm, phase 2 trial.
Sun C, Liu Y, Zhang P, Wang X, Xu Y, Lin X, Ma X, Guo Y, Qiu S, Shao G, Yang Z, Ma K. Sun C, et al. Among authors: lin x. J Cancer Res Clin Oncol. 2023 Feb;149(2):819-831. doi: 10.1007/s00432-021-03896-w. Epub 2022 Feb 22. J Cancer Res Clin Oncol. 2023. PMID: 35192053 Clinical Trial.
RETRACTED: Long non-coding RNA LINC00525 promotes the non-small cell lung cancer progression by targeting miR-338-3p/IRS2 axis.
Yang Z, Lin X, Zhang P, Liu Y, Liu Z, Qian B, Liu X, Shao G. Yang Z, et al. Among authors: lin x. Biomed Pharmacother. 2020 Apr;124:109858. doi: 10.1016/j.biopha.2020.109858. Epub 2020 Jan 25. Biomed Pharmacother. 2020. Retraction in: Biomed Pharmacother. 2023 Apr;160:114278. doi: 10.1016/j.biopha.2023.114278. PMID: 31991382 Free article. Retracted.
20,683 results
You have reached the last available page of results. Please see the User Guide for more information.